Cargando…
The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma
OBJECTIVES: The development of novel agents and an ageing population has led to an increasing number of patients with follicular lymphoma (FL) living longer with their disease. Health‐related quality of life (HRQOL) is a priority for patients and should guide clinical decisions. The Myeloma Patient...
Autores principales: | Davies, Joanna M., Osborne, Thomas R., Edmonds, Polly M., Schey, Steve A., Devereux, Steve, Higginson, Irene J., Ramsenthaler, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413861/ https://www.ncbi.nlm.nih.gov/pubmed/28160316 http://dx.doi.org/10.1111/ejh.12864 |
Ejemplares similares
-
Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)
por: Osborne, Thomas R, et al.
Publicado: (2015) -
Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods
por: Ramsenthaler, Christina, et al.
Publicado: (2017) -
The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study
por: Ramsenthaler, Christina, et al.
Publicado: (2016) -
Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life
por: Osborne, Thomas R, et al.
Publicado: (2014) -
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care
por: Gerlach, Christina, et al.
Publicado: (2020)